Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?

Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24376

Title:	Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?
Authors:	Driessen, J. H. M. Knapen, L. M. GEUSENS, Piet VAN DEN BERGH, Joop
Issue Date:	2017
Publisher:	SPRINGER LONDON LTD
Source:	OSTEOPOROSIS INTERNATIONAL, 28(8), p. 2429-2430
Notes:	[Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands. [Driessen, J. H. M.; van den Bergh, J. P. W.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands. [Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands. [Driessen, J. H. M.] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Hasselt Univ, Biomed Res Ctr, Agoralaan Gebouw D, B-3590 Diepenbeek, Belgium. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Maastricht Univ, Med Ctr, Dept Internal Med, Subdivis Rheumatol,CAPHRI, Maastricht, Netherlands. [van den Bergh, J. P. W.] VieCuri Med Ctr, Dept Internal Med, POB 1926, NL-5900 BX Venlo, Netherlands.
Document URI:	http://hdl.handle.net/1942/24376
ISSN:	0937-941X
e-ISSN:	1433-2965
DOI:	10.1007/s00198-017-4120-2
ISI #:	000406275400020
Rights:	© International Osteoporosis Foundation and National Osteoporosis Foundation 201
Category:	A1
Type:	Journal Contribution
Validations:	ecoom 2018
Appears in Collections:	Research publications

File	Description	Size	Format
o.pdf Restricted Access	Published version	276.51 kB	Adobe PDF	View/Open Request a copy

Check